Section Arrow
Quote
PTHS.NYSE-M
- Pelthos Therapeutics Inc
Quotes are at least 15-min delayed:2025/07/03 11:21 EDT
Last
 15.69
-0.81 (-4.91%)
Day High 
17.8 
Prev. Close
16.5 
1-M High
18.8 
Volume 
9.90K 
Bid
15.2
Ask
16.69
Day Low
13.881 
Open
14.41 
1-M Low
10 
Market Cap 
8.90M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 12.66 
20-SMA 12.42 
50-SMA 11.68 
52-W High 38 
52-W Low 4.5 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-12.00/-1.05
Enterprise Value
8.90M
Balance Sheet
Book Value Per Share
-6.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
WINTWindtree Therapeutics Inc.0.910504+0.140504+18.25%0.84PE
LIXTLixte Biotechnology Holdings2.76+0.74+36.63%-- 
NCNANuCana plc0.0527-0.0038-6.73%-- 
VORVor Biopharma1.7503+0.3003+20.71%-- 
CMNDClearmind Medicine1.0201+0.1171+12.97%0.16PE
Quotes are at least 15-min delayed：2025/07/03 11:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.